Nationwide, the percentage of health care visits for flulike symptoms ticked up above the baseline at the start of November and has remained elevated ever since, according to the Centers for Disease Control and Prevention.
Category: Infectious Diseases
Going beyond B cells in the search for a more multi-targeted vaccine
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
Searching for vaccine variability in the land of the flu
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
The hunt for a vaccine that fends off not just a single viral strain, but a multitude
Stanford Medicine researchers are designing vaccines that might protect people from not merely individual viral strains but broad ranges of them. The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
As seasons change, so does the guidance around antibiotics: Here’s what you need to know now
Clinical fellow Alex Zimmet, MD, a member of Stanford Medicine’s antimicrobial stewardship team, discusses why antibiotic overuse is a problem and how you can help combat it.
mRNA Nobel spotlights promise of future vaccine technology and more
Post-Nobel Prize announcement, we're spotlighting the science behind the mRNA-based COVID-19 vaccine and how it may impact medicine broadly.
What you need to know this vaccination season
Stanford Medicine infectious disease expert Anne Liu provides guidance on the RSV, flu and new COVID-19 vaccines this fall.
mRNA vaccine spike protein differs from viral version
Scientists explain a key difference between the spike-protein molecules generated by the SARS-CoV-2 mRNA vaccine and those the virus induces.
Tuberculosis in prisons poses broader problems
Researchers at Stanford Medicine have shown that, globally, the rate of tuberculosis in prisons also drives tuberculosis in the community.
A new, artistic perspective on plastic waste
Stanford Medicine scientist Desiree LaBeaud partnered with artist Jean Shin to create art of our discarded plastic.
mRNA medicines: Looking back, and a look forward
Stanford Medicine experts discuss the past successes and future potential of mRNA as a new type of medicine or treatment.
Researchers team with CDC to expand adult hepatitis B testing
New CDC recommendation for universal hepatitis B screening could significantly reduce liver cancer in Asians and Black people, researchers say.
Runaway immune reactions cause long COVID breathing problems
Researchers at Stanford Medicine have investigated the mechanism of pulmonary fibrosis caused by long COVID.
Why watch the wastewater? It could be a boon for public health
Two microbiology and health policy experts discuss the potential and pitfalls of a wastewater surveillance system.
Study counts mortality among doctors during pandemic
Despite more exposure to COVID-19, physicians experienced a lower excess mortality rate than Americans overall
Special delivery 2.0: CARTs
Researchers at Stanford are devising new ways to deliver mRNA to the body to facilitate more potent and accurate treatments and vaccines.